Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVIDENCE: Everolimus Regimens in Kidney Transplant
NCT01023815Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in kidney transplant rejection, sponsored by Novartis. Started Apr 2009; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01023815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01023815.